A molecular diagnostic kit for BRAF mutation detection. Used in solid tumour oncology for identifying BRAF gene mutations associated with melanoma and other cancers.
Manufactured by
TRUPCR Europe Ltd
Manchester, United Kingdom
TRUPCR Europe Ltd appears to be a technology company with an online presence at trupcr.com. Based on their website, they maintain digital operations that require secure connections and cookie-enabled browsing for optimal functionality. The company serves users through their web platform, prioritizing site security and proper browser configuration for seamless access.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
PlexBio Co., Ltd.
Taiwan · 4 relevant products
Xi'an Tianlong Science And Technology Co., Ltd
China · 1 relevant product
3B BlackBio Dx - TRUPCR Europe - CORIS BioConcept
India · 3 relevant products
50 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →11 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 25 relevant matches
PlexBio Co., Ltd. · Taiwan
A qualitative diagnostic test for the detection of 7 somatic mutations in the BRAF gene. This kit is used for targeted mutation analysis in cancer diagnostics.
3B BlackBio Dx - TRUPCR Europe - CORIS BioConcept · India
Diagnostic kit for detecting relevant mutations in colorectal cancer tissue samples. Identifies mutations affecting prognosis and treatment selection.
HymonBio Co., Ltd. · China
In vitro diagnostic kit for detecting KRAS gene mutations in patient samples. Enables rapid molecular identification of KRAS mutations for oncology treatment planning and patient stratification. Supports precision medicine approaches in cancer care.
22 more relevant matches available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products